Schedule 13G ownership disclosure

Kitov Pharmaceuticals Holdings Ltd.

Security class unavailable · CUSIP: 49803V107

Event date: 2019-01-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,714,286
Percent of class
8.8200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000052
Form type
SC 13G
Filer
PURPLE BIOTECH LTD.
CIK
CIK 1614744
Filed
Jan 16, 2019
Reporting period
Jan 16, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub